FairValueLabs Valuation System Value-Speculation
SNPS

Synopsys, Inc. (SNPS) Stock Analysis — Fair Value, Risk & Moat Rating

NMS · Technology · Software - Infrastructure

$477.26 Overvalued 9.68 (2.1%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
3.39
Altman Z-ScoreSafe Zone
$331.60
Fair ValueOvervalued (-43.9%)
3.1
Moat RatingNarrow moat
TL;DR · Audit Summary

Is Synopsys, Inc. a safe investment right now?

Synopsys, Inc.'s Altman Z-Score of 3.39 places it in the safe zone. Our fair value estimate is $331.60 (Overvalued). Moat rating: 3.1/5 stars.

Price Chart · SNPS
Section 01 · Financial Health

Could Synopsys, Inc. go bankrupt? Altman Z-Score analysis

3.39

Z-Score of 3.39 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives SNPS's Z-Score?

Altman Z-Score components for SNPS
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA0.04751.20.06
B · Retained Earnings / Total AssetsRE / TA0.21391.40.3
C · EBIT / Total AssetsEBIT / TA0.03823.30.13
D · Market Cap / Total LiabilitiesMCap / TL4.59480.62.76
E · Revenue / Total AssetsRev / TA0.14631.00.15

How has SNPS's financial health changed over time?

3.0 Safe1.8 Distress0.04.69.213.818.32022202320242025
SNPS Z-Score history
YearZ-ScoreZone
202215.95Safe
202315.12Safe
202415.72Safe
20253.39Safe

Source: Calculated from SNPS's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is Synopsys, Inc. actually worth?

FVL Fair Value$331.60
vs
Market Price$477.26
Overvalued -43.9% Stock trades 43.9% above our estimated fair value of $331.60.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$8.29Proprietary blend of reported actuals (1Q actual) + analyst consensus, weighted by α
Last Year EPS$8.04Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$14.4526 analysts consensus
Trailing P/E73.0xCurrent market pricing
Fair P/E (β discount)40.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)AcceleratingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $534.65 (26 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Synopsys, Inc. have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.1/5.

What makes up SNPS's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★☆☆☆

Gross margin trajectory over the past decade. Score: 2/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is SNPS's return on invested capital?

0%-5%3%11%18%26%2022202320242025
SNPS ROIC history
YearROICTrend
202220.0%
202321.2%Rising
202417.2%Declining
20254.4%Declining

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Synopsys, Inc.'s dividend safe?

Status Suspended Synopsys, Inc. has suspended its dividend. No payout is currently being made to shareholders.
Section 05 · Financial Summary

Synopsys, Inc.'s key financial metrics

SNPS financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $7.1B $6.1B $4.6B Rising
Net Income $1.3B $2.3B $1.0B Rising
Free Cash Flow $1.3B $1.3B $1.6B Declining
Gross Margin 77.0% 79.7% 80.5% Stable
Section 06 · Lab Signals

Recent events that affect our SNPS analysis

EARNINGS

SNPS earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $3.15. Revenue estimate: $2.25B. Our current Fair Value: $331.60 — a significant beat or miss could shift this estimate.

ANALYST

SNPS analyst consensus: 68% bullish (17 of 25 analysts)

Lab Impact

2 Strong Buy, 15 Buy, 7 Hold, 0 Sell, 1 Strong Sell. Consensus target: $534.65 (12.0% upside). Compare with our independent Fair Value: $331.60.

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

SNPS beat EPS estimates by 6.0%

Lab Impact

Reported EPS: $3.77 vs estimate $3.56. Earnings strength supports our Fair Value of $331.60 (30.5% below current price).

FILING

SNPS filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

SNPS beat EPS estimates by 0.7%

Lab Impact

Reported EPS: $2.90 vs estimate $2.88. Earnings strength supports our Fair Value of $331.60 (30.5% below current price).

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

SNPS missed EPS estimates by 44.3%

Lab Impact

Reported EPS: $1.50 vs estimate $2.69. Our Fair Value of $331.60 may face downward pressure if the trend continues.

FILING

SNPS filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

SNPS beat EPS estimates by 8.0%

Lab Impact

Reported EPS: $3.67 vs estimate $3.40. Earnings strength supports our Fair Value of $331.60 (30.5% below current price).

FILING

SNPS filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

SNPS beat EPS estimates by 8.6%

Lab Impact

Reported EPS: $3.03 vs estimate $2.79. Earnings strength supports our Fair Value of $331.60 (30.5% below current price).

FILING

SNPS filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

SNPS filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about Synopsys, Inc.

What is Synopsys, Inc. stock price today?

Synopsys, Inc. (SNPS) stock price is $477.26 as of the latest market close, traded on the NASDAQ exchange.

What does Synopsys, Inc. do?

Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP.

What is Synopsys, Inc. market cap?

Synopsys, Inc. has a market capitalization of $91.42B, classifying it as a large-cap stock in the Technology sector.

What sector and industry is SNPS in?

Synopsys, Inc. operates in the Technology sector, specifically within the Software - Infrastructure industry. It trades on the NASDAQ under the ticker symbol SNPS.

Is SNPS stock overvalued or undervalued?

Based on our valuation model, Synopsys, Inc. trades 43.9% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $331.60
  • Current Price: $477.26
  • Valuation Zone: Overvalued
What is SNPS stock forecast and analyst target price?

Based on 26 Wall Street analysts, the consensus price target for Synopsys, Inc. is $534.65, implying upside of 12.0% from the current price.

  • Analyst High Target: $650.00
  • Analyst Low Target: $403.85

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Synopsys, Inc. revenue and earnings growing?

Here are the analyst consensus growth estimates for Synopsys, Inc.:

  • Revenue growth (current year est.): 36.5%
  • EPS growth (current year est.): 11.9%
  • Revenue growth (next year est.): 10.7%
  • EPS growth (next year est.): 18.0%
What are Synopsys, Inc.'s key financial metrics?
MetricLatestTrend
Revenue$7.1BRising
Net Income$1.3BRising
Free Cash Flow$1.3BDeclining
Gross Margin77.0%Stable
What is SNPS's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 73.0x
  • Forward P/E (next 12 months est.): 28.0x
  • FairValueLabs Fair P/E: 40.0x
How volatile is SNPS stock?

Synopsys, Inc. has a beta of 1.15, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Synopsys, Inc. have?

Synopsys, Inc.'s balance sheet shows:

  • Total Cash: $2.20B
  • Total Debt: $10.87B
  • Net Cash Position: $-8.67B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Synopsys, Inc.'s free cash flow?

Synopsys, Inc. generated $3.10B in trailing twelve-month free cash flow (from $2.44B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Synopsys, Inc. pay a dividend?

Synopsys, Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.

Is Synopsys, Inc. at risk of going bankrupt?

Synopsys, Inc.'s Altman Z-Score is 3.39, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Synopsys, Inc. have a durable competitive advantage?

Synopsys, Inc. scores 3.1/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 2/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is SNPS's return on equity (ROE)?

Synopsys, Inc.'s return on equity is 5.5%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy SNPS stock?

SNPS shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol SNPS
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is SNPS a value stock or speculative?

FairValueLabs classifies Synopsys, Inc. as Value-Speculation. It has some value characteristics but carries elevated risk factors that make it speculative. Extra due diligence is recommended.

Who is the CEO of Synopsys, Inc.?

The current CEO of Synopsys, Inc. is Mr. Sassine Ghazi.

What is SNPS's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $6.54
  • Forward EPS (next 12 months est.): $17.05
  • Analyst consensus EPS (this year): $14.45
  • Analyst consensus EPS (next year): $17.05

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

SNPS analysis methodology: How we calculate fair value, Z-Scores, and moat ratings